SAG
SageView Advisory Group’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.23M | Buy |
22,424
+4,020
| +22% | +$758K | 0.16% | 74 |
|
|
2025
Q1 | $3.86M | Buy |
18,404
+474
| +3% | +$99.3K | 0.16% | 69 |
|
|
2024
Q4 | $3.19M | Buy |
17,930
+5,327
| +42% | +$947K | 0.14% | 83 |
|
|
2024
Q3 | $2.49M | Sell |
12,603
-5,862
| -32% | -$1.16M | 0.13% | 98 |
|
|
2024
Q2 | $3.17M | Buy |
18,465
+3,935
| +27% | +$675K | 0.15% | 85 |
|
|
2024
Q1 | $2.65M | Sell |
14,530
-7,768
| -35% | -$1.41M | 0.13% | 90 |
|
|
2023
Q4 | $3.68M | Buy |
22,298
+9,460
| +74% | +$1.56M | 0.16% | 80 |
|
|
2023
Q3 | $1.91M | Sell |
12,838
-188
| -1% | -$28K | 0.11% | 116 |
|
|
2023
Q2 | $1.75M | Sell |
13,026
-242
| -2% | -$32.6K | 0.1% | 127 |
|
|
2023
Q1 | $2.11M | Buy |
13,268
+3,142
| +31% | +$501K | 0.13% | 109 |
|
|
2022
Q4 | $1.64M | Buy |
+10,126
| New | +$1.64M | 0.13% | 108 |
|